« Return to News | Awards & Advancement

Pusey Appointed President, CEO of Omnicare Clinical Research

Tuesday, October 20, 2009 08:01 AM

Omnicare appointed James Pusey as president and CEO of Omnicare Clinical Research. In his new position, Pusey will be responsible for Omnicare’s contract research organization (CRO) operations worldwide.

Pusey succeeds Dr. Dale B. Evans, who has resigned to pursue other opportunities. 

“Dr. Pusey has a wealth of experience in all aspects of the CRO business—from research and drug development to operations, sales and customer relationships—and we believe he will add significant value to our organization,” said Joel Gemunder, Omnicare’s president and CEO.

“Under Dr. Pusey’s leadership, we look forward to leveraging the organization’s assets to further strengthen Omnicare’s presence in the clinical research business, and to develop new growth opportunities. “Omnicare’s CRO operations, including Omnicare Clinical Research, headquartered in King of Prussia, Penn., and Clinimetrics Research Associates, based in San Jose, Calif., provide comprehensive product development and research services.

Pusey added, “Omnicare has a CRO platform that not only has a full complement of drug development and commercialization services across a broad global footprint but also has unique opportunities in the biotech arena and in geriatric research. I am encouraged by the long-term outlook for the CRO industry and by the prospects inherent in Omnicare’s CRO business.”

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.